Daniel L Gustafson

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Venues

Pharmacology research & perspectives

BMC medical genomics

BMC bioinformatics

Neuro-oncology

University of Nevada, Reno (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Nevada, Reno

United States

PHD :: Cell and Molecular Pharmacology & Physiology

Santa Clara University

United States

BSC :: Biology

Publications

Sandra Witta, Keagan P Collins, Dominique A Ramirez, Joshua D Mannheimer, Luke A Wittenburg, Daniel L Gustafson
Vinblastine pharmacokinetics in mouse, dog, and human in the context of a physiologically based model incorporating tissue-specific drug binding, transport, and metabolism. Pharmacology research & perspectives 11 (1) (2023)
Daniel L Gustafson, Lindsey O Viola, Christina G Towers, Sunetra Das, Dawn L Duval, Kristen M Van Eaton
Sensitivity of osteosarcoma cell lines to autophagy inhibition as determined by pharmacologic and genetic manipulation. Veterinary and comparative oncology (2023)
Sandra Witta, Keagan P Collins, Dominique A Ramirez, Joshua D Mannheimer, Luke A Wittenburg, Daniel L Gustafson
Vinblastine pharmacokinetics in mouse, dog, and human in the context of a physiologically based model incorporating tissue-specific drug binding, transport, and metabolism. Pharmacology research & perspectives 11 (1) (2023)
Arthur R Wolin, Melanie Y Vincent, Taylor Hotz, Stephen C Purdy, Sheera R Rosenbaum, Connor J Hughes, Jessica Y Hsu, Michael U J Oliphant, Brock Armstrong, Veronica Wessells, Marileila Varella-Garcia, Matthew D Galbraith, Angela Pierce, Dong Wang, Sujatha Venkataraman, Etienne Danis, Bethany Veo, Natalie Serkova, Joaquín Maximiliano Espinosa, Daniel L Gustafson, Rajeev Vibhakar, Heide L Ford
EYA2 Tyrosine Phosphatase Inhibition Reduces MYC and Prevents Medulloblastoma Progression. Neuro-oncology (2023)
Sandra Witta, Keagan P Collins, Dominique A Ramirez, Joshua D Mannheimer, Luke A Wittenburg, Daniel L Gustafson
Vinblastine pharmacokinetics in mouse, dog, and human in the context of a physiologically based model incorporating tissue-specific drug binding, transport, and metabolism. Pharmacology research & perspectives 11 (1) (2023)
Sandra Witta, Keagan P Collins, Dominique A Ramirez, Joshua D Mannheimer, Luke A Wittenburg, Daniel L Gustafson
Vinblastine pharmacokinetics in mouse, dog, and human in the context of a physiologically based model incorporating tissue-specific drug binding, transport, and metabolism. Pharmacology research & perspectives 11 (1) (2023)
Seth P Lerner, David J McConkey, Catherine M Tangen, Joshua J Meeks, Thomas W Flaig, Xing Hua, Siamak Daneshmand, Ajjai Shivaram Alva, M Scott Lucia, Dan Theodorescu, Amir Goldkorn, Matthew I Milowsky, Woonyoung Choi, Rick Bangs, Daniel L Gustafson, Melissa Plets, Ian M Thompson
Association of Molecular Subtypes with Pathologic Response, PFS and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Joshua D Mannheimer, Ashok Prasad, Daniel L Gustafson
Predicting chemosensitivity using drug perturbed gene dynamics. BMC bioinformatics 22 (1) (2021)
Daniel L Gustafson, Keagan P Collins, Jared S Fowles, E J Ehrhart, Kristen M Weishaar, Sunetra Das, Dawn L Duval, Douglas H Thamm
Prospective clinical trial testing COXEN-based gene expression models of chemosensitivity in dogs with spontaneous osteosarcoma. Cancer chemotherapy and pharmacology 88 (4) (2021)
Joshua D Mannheimer, Dawn L Duval, Ashok Prasad, Daniel L Gustafson
A systematic analysis of genomics-based modeling approaches for prediction of drug response to cytotoxic chemotherapies. BMC medical genomics 12 (1) (2019)

Daniel L Gustafson.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel L Gustafson